Zhejiang Xinguang Pharmaceutical Co Ltd

300519 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

14.45CNY-0.51 (-3.41%)

Price History

Full chart

Market Stats

Previous Close14.96

Open14.90

Day Range14.35 – 15.02

52-Week Range11.53 – 17.87

Volume4.43M

Market Cap2.37B

P/E (TTM)38.00

Forward P/E0.00

EPS0.39

Dividend Yield2.02%

Beta0.31

50-Day Avg14.20

200-Day Avg14.86

About

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers Chinese patent medicines, chemical medicines, and health food in various forms, including tablets, mixtures, granules, syrups, powders, hard capsules, and oral liquids, as well as drinks. Its products are used for the treatment of cardiovascular, trauma, respiratory, digestive, urinary, pediatric, and immunity diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Yue Jun Wang
Employees309
HeadquartersNo. 25, Huancheng West Road, Shengzhou, China, 312400, China
Websitehttps://www.xgpharma.com

Leadership

Mr. Yue Jun WangChairman & GM · b. 1954
Ms. Bin Bin XingCFO, Accounting Supervisor & Director · b. 1975
Mr. Fu Yin QiuDeputy GM & Director · b. 1962
Mr. Yuan Yang JiangDeputy GM, Secretary of the Board & Director · b. 1968

Financials

Income Statement

Currency: CNY	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	229.62M	249.85M	267.94M	292.11M	311.48M	315.31M	310.87M	276.26M	291.26M	283.08M	320.88M	351.49M	270.40M	267.66M	265.36M
Growth (%)	-	+8.81%	+7.24%	+9.02%	+6.63%	+1.23%	-1.41%	-11.13%	+5.43%	-2.81%	+13.35%	+9.54%	-23.07%	-1.01%	-0.86%
Cost of Revenue	139.90M	134.57M	123.41M	108.87M	107.53M	111.29M	125.05M	125.57M	133.06M	128.68M	145.29M	169.81M	160.03M	177.89M	162.50M
Gross Profit	89.72M	115.28M	144.53M	183.24M	203.95M	204.02M	185.81M	150.69M	158.21M	154.40M	175.58M	181.68M	110.37M	89.77M	102.86M
Gross Margin	39.07%	46.14%	53.94%	62.73%	65.48%	64.71%	59.77%	54.55%	54.32%	54.54%	54.72%	51.69%	40.82%	33.54%	38.76%
Operating Expense	33.60M	55.26M	62.64M	61.15M	66.34M	72.01M	63.30M	49.65M	49.57M	41.90M	43.00M	55.07M	36.24M	32.42M	54.50M
Operating Income	56.12M	60.03M	81.89M	122.08M	137.60M	132.01M	122.51M	101.04M	108.63M	112.49M	132.58M	126.60M	74.13M	57.35M	48.36M
Operating Margin	24.44%	24.03%	30.56%	41.79%	44.18%	41.87%	39.41%	36.58%	37.30%	39.74%	41.32%	36.02%	27.42%	21.42%	18.22%
EBITDA	40.55M	62.62M	90.83M	129.00M	144.07M	144.61M	128.63M	114.54M	118.49M	127.34M	144.83M	139.67M	87.95M	71.95M	63.09M
EBITDA Margin	17.66%	25.06%	33.90%	44.16%	46.25%	45.86%	41.38%	41.46%	40.68%	44.98%	45.14%	39.74%	32.53%	26.88%	23.78%
Net Income	46.85M	56.84M	72.47M	105.65M	118.78M	118.96M	106.16M	88.00M	93.90M	98.98M	114.28M	108.82M	64.36M	50.39M	54.21M
Net Income Margin	20.41%	22.75%	27.05%	36.17%	38.14%	37.73%	34.15%	31.85%	32.24%	34.96%	35.62%	30.96%	23.80%	18.83%	20.43%
R&D	6.75M	10.88M	12.85M	11.31M	14.11M	15.11M	18.67M	17.77M	15.90M	12.01M	13.52M	15.55M	15.13M	12.62M	13.35M
R&D as % of Total Revenue	2.94%	4.36%	4.80%	3.87%	4.53%	4.79%	6.00%	6.43%	5.46%	4.24%	4.21%	4.42%	5.60%	4.72%	5.03%
Interest Expense	0	2.47M	669.30K	85.40K	80.80K	65.15K	18.95K	16.86K	14.93K	14.00K	14.54K	13.93K	15.77K	13.64K	-
Interest Expense % of Total Revenue	0.00%	0.99%	0.25%	0.03%	0.03%	0.02%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.01%	0.01%	-

Balance Sheet

Currency: CNY	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	219.35M	217.44M	246.26M	303.10M	362.87M	700.95M	775.05M	822.50M	861.13M	890.79M	932.40M	957.76M	930.41M	909.78M	889.42M
Total Liabilities	115.03M	75.82M	44.29M	54.10M	53.52M	60.49M	69.24M	69.24M	61.42M	63.84M	86.19M	98.86M	86.29M	79.25M	52.60M
Total Equity	102.31M	141.62M	201.97M	249.00M	309.35M	640.46M	705.81M	753.26M	799.71M	826.94M	846.22M	858.89M	844.12M	830.53M	836.81M
Cash	61.76M	81.52M	101.31M	122.62M	175.36M	336.63M	376.54M	406.49M	407.35M	591.85M	593.67M	622.03M	543.95M	503.42M	311.84M
Total Debt	50.00M	22.00M	3.00M	1.00M	1.00M	2.36M	2.36M	2.36M	2.36M	-	-	-	-	-	-
Net Debt	-11.76M	-59.52M	-98.31M	-121.62M	-174.36M	-334.27M	-374.18M	-404.13M	-404.99M	-591.85M	-593.67M	-622.03M	-543.95M	-503.42M	-

Cash Flow

Currency: CNY	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	34.40M	53.93M	57.51M	99.82M	124.84M	121.18M	124.23M	92.77M	98.27M	112.61M	142.36M	126.43M	53.29M	53.43M	68.92M
Investing Cash Flow	44.67M	14.88M	-6.04M	-16.43M	-12.03M	-171.56M	-44.33M	-22.82M	-49.40M	143.88M	-44.54M	-2.07M	-51.37M	-29.96M	-
Financing Cash Flow	-81.37M	-49.06M	-31.68M	-62.07M	-60.06M	211.65M	-40.00M	-40.00M	-48.00M	-72.00M	-96.00M	-96.00M	-80.00M	-64.00M	-
Capital Expenditure	5.83M	3.02M	7.22M	21.85M	14.84M	22.27M	30.40M	21.27M	16.00M	10.27M	14.71M	16.64M	15.99M	5.20M	3.48M
Free Cash Flow	-5.83M	50.92M	50.29M	77.97M	110.00M	98.91M	93.83M	71.51M	82.27M	102.34M	127.64M	109.78M	37.30M	48.23M	65.45M
Dividends Paid	122.41M	21.06M	12.68M	60.07M	60.06M	45.60K	40.00M	40.00M	48.00M	72.00M	96.00M	96.00M	80.00M	64.00M	48.00M
FCF to OCF	-16.95%	94.41%	87.44%	78.12%	88.11%	81.62%	75.53%	77.08%	83.72%	90.88%	89.66%	86.83%	70.00%	90.27%	94.96%
Dividend Paid to FCF	-2099.34%	41.37%	25.22%	77.04%	54.60%	0.05%	42.63%	55.94%	58.34%	70.35%	75.21%	87.44%	214.46%	132.69%	73.34%

Earnings

Report Date	Oct 27, 2016	Feb 28, 2017	Apr 25, 2017	Aug 14, 2017	Oct 27, 2017	Dec 31, 2017	Apr 26, 2018	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Apr 29, 2020	Aug 26, 2020	Oct 28, 2020	Dec 31, 2020	Apr 28, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	May 17, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	May 16, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.17	0.22	0.21	0.11	0.15	0.19	0.21	0.05	0.15	0.14	0.20	0.07	0.16	0.15	0.17	0.12	0.18	0.15	0.24	0.11	0.19	0.16	0.27	0.11	0.18	0.12	0.19	0.05	0.13	0.04	0.14	0.02	0.08	0.08	0.15	0.05	0.08	0.06	0.16	0.08
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	Pre-market	After-hours	Pre-market	After-hours	Pre-market	-	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	-	-	-	After-hours	-	-	-	-	-

Key Statistics & Ratios

Market Cap2.37B

Enterprise Value1.60B

Trailing P/E38.00

Forward P/E0.00

Price / Sales8.88

Price / Book2.82

EPS0.39

Book Value5.18

Revenue (TTM)267.01M

Gross Profit (TTM)116.75M

EBITDA77.16M

Profit Margin23.23%

Operating Margin21.29%

Return on Equity7.55%

Return on Assets4.48%

Shares Outstanding160.00M

Shares Float78.00M

Beta0.31

Dividend Yield2.02%

Dividend Rate0.30

Payout Ratio77.40%

Dividends

20261×

0.30May 29, 2026

20251×

0.30May 28, 2025

20241×

0.40May 29, 2024

20231×

0.50May 30, 2023

20221×

0.60May 26, 2022

20211×

0.60May 28, 2021

20201×

0.45May 27, 2020

20191×

0.30May 29, 2019

20181×

0.25May 29, 2018

20171×

0.25Jul 4, 2017

Stock Splits

Jul 4, 201720:10